Luke Sergott
Stock Analyst at Barclays
(2.12)
# 2,716
Out of 4,832 analysts
278
Total ratings
38.39%
Success rate
-6.96%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTRE Fortrea Holdings | Maintains: Underweight | $6 → $5 | $4.60 | +8.70% | 10 | May 13, 2025 | |
| NTRA Natera | Maintains: Overweight | $160 → $190 | $151.35 | +25.54% | 3 | May 9, 2025 | |
| CERT Certara | Upgrades: Overweight | $11 → $14 | $11.66 | +20.07% | 17 | May 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $145 → $155 | $140.22 | +10.54% | 6 | May 8, 2025 | |
| BRKR Bruker | Maintains: Overweight | $50 → $46 | $38.15 | +20.58% | 4 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Equal-Weight | $170 → $165 | $145.47 | +13.43% | 22 | May 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Equal-Weight | $165 → $155 | $134.71 | +15.06% | 19 | May 2, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $55 → $75 | $52.25 | +43.54% | 4 | May 2, 2025 | |
| GH Guardant Health | Maintains: Overweight | $55 → $60 | $41.27 | +45.38% | 3 | May 1, 2025 | |
| AVTR Avantor | Maintains: Overweight | $18 → $15 | $13.19 | +13.72% | 24 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $205 → $215 | $191.37 | +12.35% | 39 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $350.57 | -0.16% | 18 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $45 | $30.87 | +45.77% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $620 → $475 | $414.40 | +14.62% | 24 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $12 | $12.94 | -7.26% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $110 | $92.52 | +18.89% | 9 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $77 | $79.58 | -3.24% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $138 → $115 | $112.64 | +2.10% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $12 | $9.53 | +25.92% | 11 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $3 → $2 | $1.13 | +76.99% | 4 | May 10, 2024 |
Fortrea Holdings
May 13, 2025
Maintains: Underweight
Price Target: $6 → $5
Current: $4.60
Upside: +8.70%
Natera
May 9, 2025
Maintains: Overweight
Price Target: $160 → $190
Current: $151.35
Upside: +25.54%
Certara
May 8, 2025
Upgrades: Overweight
Price Target: $11 → $14
Current: $11.66
Upside: +20.07%
Charles River Laboratories International
May 8, 2025
Maintains: Equal-Weight
Price Target: $145 → $155
Current: $140.22
Upside: +10.54%
Bruker
May 8, 2025
Maintains: Overweight
Price Target: $50 → $46
Current: $38.15
Upside: +20.58%
IQVIA Holdings
May 7, 2025
Maintains: Equal-Weight
Price Target: $170 → $165
Current: $145.47
Upside: +13.43%
ICON Public Limited Company
May 2, 2025
Maintains: Equal-Weight
Price Target: $165 → $155
Current: $134.71
Upside: +15.06%
Exact Sciences
May 2, 2025
Maintains: Overweight
Price Target: $55 → $75
Current: $52.25
Upside: +43.54%
Guardant Health
May 1, 2025
Maintains: Overweight
Price Target: $55 → $60
Current: $41.27
Upside: +45.38%
Avantor
Apr 28, 2025
Maintains: Overweight
Price Target: $18 → $15
Current: $13.19
Upside: +13.72%
Apr 22, 2025
Maintains: Overweight
Price Target: $205 → $215
Current: $191.37
Upside: +12.35%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $350.57
Upside: -0.16%
Apr 10, 2025
Maintains: Overweight
Price Target: $58 → $45
Current: $30.87
Upside: +45.77%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $620 → $475
Current: $414.40
Upside: +14.62%
Apr 10, 2025
Maintains: Overweight
Price Target: $16 → $12
Current: $12.94
Upside: -7.26%
Apr 10, 2025
Maintains: Overweight
Price Target: $140 → $110
Current: $92.52
Upside: +18.89%
Apr 10, 2025
Maintains: Underweight
Price Target: $100 → $77
Current: $79.58
Upside: -3.24%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $138 → $115
Current: $112.64
Upside: +2.10%
Apr 10, 2025
Maintains: Overweight
Price Target: $15 → $12
Current: $9.53
Upside: +25.92%
May 10, 2024
Maintains: Equal-Weight
Price Target: $3 → $2
Current: $1.13
Upside: +76.99%